Reporting Segment Product Line Amount (USD)arrow_drop_up Percentage
keyboard_arrow_right Reporting Segment & Product Line Amount (USD) Percentage
Oncology Therapies
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
1.49M 100.00%
keyboard_arrow_right keyboard_arrow_down
Oncology Therapies
Pre-Revenue Pharmaceuticals
1.49M 100.00%
keyboard_arrow_right
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.